Novartis CEO Narasimhan sets up new leadership after four top exits
Narasimhan, who took over as CEO in February, is emphasising the role of digital technology in helping Novartis come up with winning new therapies12-03-2018
Novartis CEO Narasimhan sets up new leadership after four top exits
Narasimhan, who took over as CEO in February, is emphasising the role of digital technology in helping Novartis come up with winning new therapiesWhat to Watch: Novartis India gets 188-cr refund booster
Shares of Novartis India will remain in focus following receipt of an income tax refund. In a notice to the stock exchanges, the company has said that on accounAnnouncement under Regulation 30 (LODR)-Updates
Disclosure under SEBI (LODR) Regulations - Novartis India Limited ('Company') receives refund of INR 1879m on account of favourable order of the Income Tax Appellate Tribunal for FY 1994-95.Novartis' take on what to expect as tech transforms healthcare
We will need to focus on true breakthroughs, therapies that are truly transformative - either life enhancing or meaningfully life changing.Shareholding for the Period Ended February 06, 2018
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended February 06, 2018. For more details, kindly Click hereUpdates on Buyback Offer
Ambit Capital Pvt Ltd ("Manager to the Buyback Offer") has submitted to BSE a copy of Post Buyback Public Announcement for the attention of Equity Shareholders / Beneficial Owners of Equity Shares of Novartis India Ltd ("the Company").Buy back
1. Extinguishment of equity shares as a result of the conclusion of buyback of 34,50,000 equity shares of face value of INR 5 each of Novartis India Limited (the 'Company'). 2. Reconciliation of share capital of the CompanyNovartis India Q3 net profit soars 44 per cent at Rs 187.4 million
Novartis India also announced the appointment of Jawed Zia as vice chairman and managing director of the company effective March 1, 2018Newspaper Publication
Newspaper advertisement of Post Buyback Public Announcement in respect of Buyback of equity shares of Novartis India Limited through the tender offer route Dear Sirs, Please find enclosed copies of Post Buyback Public Announcement, which has been published in the Financial Express, Jansatta and Navshakti on January 26, 2018, the contents of which are self-explanatory....Appointment of Managing Director
Outcome of Board Meeting Dear Sirs, We refer to our letter dated December 29, 2017, informing you of our Board Meeting that was scheduled for today. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 2.45 p.m. The Board of Directors of the Company at this meeting approved the following:...